• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Weekly Roundup: June 6-10


ICYMI, this week we had stories from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, FDA's approval of dupilumab, and more.

POLL: Are You Seeing More Dermatologic Symptoms Stemming From STDs?

Top Tips for Optimizing Patient Care

April Armstrong, MD, MPH, highlights her recommendations for improving patients’ outcomes, engagement, and satisfaction as part of a panel presentation at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Dupilumab May Benefit Skin Barrier Function in Patients with Atopic Dermatitis

A poster presented at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs showed normalization of skin barrier function in patients with moderate to severe atopic dermatitis taking dupilumab, according to the investigators.

Innovation in Psoriasis Therapies

In a hard-hitting session from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, April Armstrong, MD, MPH, dove into PAD technology and future innovations in psoriasis treatment.

10 Factors That Will Shape the Future of Skin Cancer Treatment

Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.

Novel Molecule Shows Preclinical Success in Treating Vemurafenib-Resistant Melanoma

New synthetic small molecule aims to counter drug resistance in BRAF-mutated melanomas.

Updates in the Medicine Chest

In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Acne and Telemedicine by the Numbers

A look at the types of visits and treatments prescribed via teledermatology during the pandemic reinforces the staying power of virtual acne care; statistics offer key details.

Melanoma screening drives overdiagnosis, more biopsies

Authors suggest not practice changes but more research.

Precision Dermatology: Takeaways for Skin Cancer, Other Conditions

Darrell S. Rigel, MD, MS, delves into the power and potential of precision medicine in diagnosis, prognosis and therapy selection.

Meeting the Challenges of Acne in Adults

A common complaint in puberty, hormonal acne also affects skin health and quality of life for adults of all genders, driving the need for new solutions.

STDs and Dermatologic Symptoms

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Rosacea Recap: The Science and the Symptom

In a session for the 2022 Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, in Scottsdale, Arizona, James Q. Del Rosso, DO, delves into new knowledge on the characteristics of this challenging skin condition.

What is Upcoming in Precision Medicine?

Darrell S. Rigel, MD, MS, FAAD, answers the question of what is up coming in the world of dermatology in the way of precision medicine.

Phase 3 Data for Roflumilast Foam 0.3% in Seborrheic Dermatitis

About 80% of patients treated with roflumilast foam 0.3% (ARQ-154, Arcutis Biotherapeutics Inc) met the primary endpoint of the trial.

Rosacea Recap: Comparing Treatment Options

James Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Factors Affecting Patients Adherence in Topical Therapies

Education, honesty, and communication skills are key for both patient and dermatologist when it comes to creating treatment regimens.

Cosmeceuticals: How to Navigate the Claim Game

Speaking at the 2022 Fall Clinical Dermatology Conference for PAs & NPs, Joshua Zeichner, MD, cut through marketing hype and misperceptions of patients to assess products that bridge cosmetics and medicine.

How to Improve Acne Treatment Regimens

Joshua Zeichner, MD, discusses how important it is to treat acne properly and gives a tip about moisturizers and topical retinoids.

Shine a New Light on Photoprotection

Recent research puts the role of sunscreens in a whole new light. Roger Ceilley MD, FAAD, FACMS outlined need-to-know information on SPF, how to improve adherence and address patient concerns about sunscreen safety and more at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Explore New Tactics for Acne Scars

Advances ranging from combined laser and drug therapies to innovative devices mean patients with acne no longer have to be scared of permanent scarring.

Assessing the Prevalence of Medication Errors in Pediatric Care

Pediatric patients taking 4 or more medications were more likely to experience medication errors.

Dupilumab FDA Approved for AD Patients 6 months to 5 years

Sanofi and Regeneron Pharmaceuticals, Inc announced the FDA approval of dupilumab. It is now the first biologic medicine for children from 6 months to 5 years old with moderate to severe atopic dermatitis.

Pointers with Dr Portela: Wrapping up Melanoma Awareness Month

In this week’s Pointers with Dr Portela, the 208SkinDoc talks about the end of Melanoma Awareness Month and gives advice on how to prevent skin cancer.

Hidradenitis Suppurativa in Pregnancy

This painful skin disease may lower the odds of live birth and trigger comorbidities.

Age Is Not Sole Predictor of Post-Surgical Outcomes in Older Patients with BCC

Age alone does not appear to predict all post-treatment outcomes for BCC patients and should not be used solely to guide BCC-related treatment decisions, a recent study says.

How to Correctly Document and Bill for Patient E-visits

The providers in our clinic want to start billing e-visits. Can they bill for all the communication between the provider and patient through our online portal?

Data Suggest Low Recurrence Rate of Nail SCC Treated with Mohs, Wide Surgical Excision

A systematic review of literature shows a shift from amputation to other surgical tactics to treat certain types of nail squamous cell carcinomas.

Examining Cells in Inflammatory Skin Disease

A recent study dove into how precision medicine can be used to better target inflammatory skin disease and provide physicians with better treatment regimens.

The Precision Medicine Revolution

The most critical step is understanding what value precision medicine brings to your practice, and where it can have greatest impact from both a clinical and business perspective.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.